Bacterial persisters are phenotypic variants with an extraordinary capacity to tolerate 27 antibiotics, and they are hypothesized to be a main cause of chronic and relapsing infections. 28
INTRODUCTION 48
Bacterial persisters are phenotypic variants that are highly tolerant to antibiotics (1). It is 49 believed that they are a main culprit of the proclivity of biofilm infections to relapse, which 50 imposes a substantial burden on the healthcare system (2, 3). When a bacterial population is 51 treated with bactericidal antibiotics, biphasic killing is observed, where the death of normal cells 52 is characterized by an initial, rapid killing rate, and the presence of persisters is illuminated by a 53 second regime with a much slower rate of cell death (4, 5) . When these survivors are re-cultured, 54 the resulting population exhibits antibiotic sensitivities identical to that of the original culture, 55 demonstrating that persisters are not antibiotic-resistant mutants, but phenotypic variants (1, 5, 56 6) . 57
While persisters largely arise from dormant subpopulations (2, 4, 7, 8) , recent studies have 58 demonstrated that they remain metabolically active, with the capacity to catabolize specific 59 carbon sources and generate proton motive force through respiration (9, 10). This metabolic 60 activity, specifically proton motive force generation, enables aminoglycoside (AG) transport into 61 cells that results in killing of persisters, and several enzymes needed for this process have been 62 identified (9, 10). Knowledge of the enzymes and metabolic pathways present in persisters, as 63 well as how they can be altered, could prove useful for the development of anti-persister 64 therapies. A fundamental question in this regard is: what are the cellular components responsible 65 for defining the metabolic network in persisters? Due to the strong dependence of metabolism on 66 transcriptional regulation (11, 12) , the goal of this study was to determine the importance of 67 several global transcriptional regulators to persister metabolism. To do this, we measured 68 catabolic activity in persisters from ΔarcA, Δcra, Δcrp, ΔdksA, Δfnr, Δlrp and ΔrpoS mutants, 69
on November 3, 2017 by guest http://aac.asm.org/ Downloaded from 6 procedure was repeated until the antibiotic concentration was below the minimal inhibitory 116 concentration (MIC). We have previously demonstrated that the MIC for MG1655 was 0.075-117 0.15 µg/mL OFL (7). After washing the cells, cell pellets were resuspended in the remaining 100 118 µL of PBS. Then, 10 µL of sample from each cell suspension was added into 90 µL PBS in a 96-119 well round bottom plate, and serially diluted. 10 µL of each dilution was spotted on LB agar 120 plates, which were then incubated at 37 °C for 16 h before the CFUs were counted. For each 121 spot, 10 to 100 colonies were counted. 122
Aminoglycoside potentiation assay 123
After 5 h of OFL treatment, cells were pelleted and resuspended in 1 mL of 1.25X M9 salt 124 solution. The cells were washed again in 1 mL of 1.25X M9 to remove the antibiotic and residual 125 LB, and the cell concentrations were adjusted such that the final concentration was ~10 and CFUs were counted. 142
Gentamicin sensitivity assay 143
E. coli MG1655Δcrp and ΔcyaA were inoculated from -80 ºC frozen stocks stored in 25% 144 glycerol into 2 mL of LB. Cells were grown for 37 ºC with shaking at 250 rpm for 4 h before 145 being diluted in 2 mL of M9 with 10 mM glucose (M9-glucose) and grown for 16 h. Cells were 146 diluted into 25 mL of M9-glucose to an OD 600 of 0.01 and cultured for 6 h until they reached 147 exponential phase. 100 µL of each culture was removed, serially diluted, and plated to enumerate 148 CFUs prior to GENT treatment. The remaining cells were then treated with 10 µg/mL of GENT 149 for 2 h. 1 mL of sample was removed from each culture, and the samples were pelleted, washed, 150 serially-diluted, and plated as described above. The plates were incubated for 16 h before CFUs 151 were counted. 152
Statistical Analysis 153
Three biological replicates were performed for each experimental condition, and a two-154 tailed t-test was performed for pairwise comparisons. p-values ≤ 0.05 were considered significant 155 and each data point has been represented by mean value ± standard error. 156 8 Due to their low abundance, transient nature, and similarities to the more highly abundant viable 161 but non-culturable cell (VBNC) phenotype, highly pure persister samples have yet to be isolated 162 (10). In the absence of such methods, we developed an approach to measure metabolic activity in 163 persisters that utilizes the phenomenon of metabolite-enabled aminoglycoside (AG) potentiation 164 (9). In brief, AG uptake is dependent on proton motive force, and therefore, this drug class has 165 an impaired ability to kill de-energized cells (9). The vast majority of persisters are 166 metabolically dormant (7), and within such a state AGs are ineffective (9). In previous work, we 167 discovered that specific metabolites produce AG killing of persisters, and that such potentiation 168 was dependent on catabolism of the substrate to generate proton motive force through respiration 169 (9, 10). This study demonstrated that persisters were metabolically active, and we have since 170
shown that the assay can be used to measure persister metabolism from antibiotic-treated 171 cultures. Notably, the approach circumvents the need to segregate persisters from other cell-172 types, because within antibiotic-treated populations that have reached the second regime of 173 biphasic killing, the only cells that remain culturable are persisters. Therefore, survival data from 174 samples treated with an AG with or without a metabolite can be used to infer persister catabolism 175 (10). Using this assay, we analyzed the impacts of ΔarcA, Δcra, Δcrp, ΔdksA, Δfnr, Δlrp and 176
ΔrpoS on the ability of persisters to consume carbon sources and generate proton motive force 177 aerobically. We focused on these transcriptional regulators due to their systems-level roles in 178 regulating metabolism, and our overall goal to identify the molecular mediators responsible for 179 establishing the persister metabolic network. Collectively, these seven global regulators govern 180 diverse aspects of E. coli metabolism: CRP and Cra participate in controlling the expression of 181 many enzymes including those within central metabolism; Lrp is involved in regulating amino 182 acid metabolism; ArcA and FNR coordinate control of aerobic and anaerobic respiration; and 183 on November 3, 2017 by guest http://aac.asm.org/
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Prior to measuring persister catabolism, we verified that five hours of ofloxacin treatment was 185 sufficient to enumerate persisters within cultures of wild-type and the seven deletion strains (Fig.  186   1 ). Persisters were then subjected to the AG potentiation assay, where samples were washed, 187 resuspended in M9 media, and exposed to a panel of 11 carbon sources (60 mM carbon) in the 188 presence of 10 μg/mL gentamicin (GENT) (Fig. 2A) . To quantify the level of GENT potentiation 189 that was metabolite independent, a no carbon source control was included. We also included 190 controls where samples were treated with 5 mM KCN in addition to carbon sources and GENT 191 to confirm that persister killing was consistent with the mechanism of AG potentiation identified 192 previously (10) (Fig. 2B-I) . plasmid), the persister abundances were comparable to that of Δcrp (Fig. 3A) . We then examined 207 the effect of crp complementation on carbon source metabolism and AG potentiation, and we 208 found that pUA66-crp restored metabolic stimulation of AG killing in Δcrp, whereas pUA66 did 209 not ( Fig. 3B-E) . Similar to Δcrp, a loss of CFUs was not detected in Δcrp with pUA66, 210 demonstrating that the vector did not interfere with carbon source consumption or AG 211 sensitivity. 212
Since CRP activates catabolic gene expression when it is bound to cyclic adenosine 213 monophosphate (cAMP), which is synthesized by adenylate cyclase encoded by cyaA, we 214 generated ΔcyaA and its complementation strains and assessed both persister levels and carbon 215 source consumption. Persister levels within ΔcyaA, ΔcyaA with pUA66, and ΔcyaA with 216 pUA66-cyaA were found to be comparable (Fig. 4A) , whereas ΔcyaA, much like Δcrp, resulted 217 in a broad reduction in the array of carbon sources that persisters could consume to potentiate 218 AG activity (Fig. 4B-E) . In addition, pUA66-cyaA, but not the control plasmid (pUA66), 219 restored carbon source consumption to persisters. 220
We note that E. coli lacking crp or cyaA may exhibit increased tolerance toward AG (25-221 27). To ensure that the reduction in metabolite-enabled AG killing observed in Δcrp and ΔcyaA 222 was due to alterations in persister metabolism rather than an inability of AGs to kill these 223 mutants, we assessed whether GENT could kill Δcrp and ΔcyaA in M9 minimal media, which 224 was the media used for AG potentiation assays. As depicted in shut-down of metabolic processes participates in entry into this quasi-dormant state; metabolic 235 activity during stasis maintains viability; and reactivation of metabolism is required for 236 reawakening and growth after the conclusion of antibiotic treatment. The importance of 237 metabolism is further highlighted by the discovery of anti-persister strategies which depend on 238 metabolic stimulation in persisters (9, (35) (36) (37) (38) . These findings advocate the need for greater 239 understanding of persister metabolism. Unfortunately, measurement of persister metabolic 240 activities with standard methods is not currently possible, due to inabilities associated with 241 isolating persisters (10, 39, 40) . However, with the AG potentiation assay we are able to measure 242 persister metabolism even in the presence of other cell types, such as VBNCs, because the 243 method deduces metabolic activity from culturability data, and the defining characteristic of 244 persistence is retention of culturability following prolonged antibiotic treatment (10). In addition, 245 the AG potentiation assay not only identifies carbon sources that persisters consume to drive 246 proton motive force generation, but it simultaneously identifies metabolite adjuvants to be used 247 with AGs to kill persisters, which is important information that is therapeutically relevant (10). 248
With the AG potentiation assay, we directly assessed the contribution of a set of global 249 transcriptional regulators to persister metabolism. We focused on these regulators, because we 250 sought to identify the cellular components responsible for defining the metabolic network in 251 
